|
시장보고서
상품코드
2008143
브루셀라증 백신 시장 : 유형별, 용도별, 지역별Brucellosis Vaccines Market, By Type, By Application, By Geography |
||||||
브루셀라증 백신 시장은 2026년에 12억 달러로 추정되고 있으며, 2033년까지 24억 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 7.3%로 성장할 것으로 전망되고 있습니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 12억 달러 |
| 실적 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년의 예측 기간 CAGR : | 7.30% | 2033년 시장 규모 예측 : | 24억 달러 |
브루셀라증은 세균에 의해 발생하는 감염성 질환입니다. 가장 많이 감염되는 동물로는 양, 소, 염소, 염소, 돼지,개 등이 있습니다. 또한 감염된 동물이나 세균에 오염된 동물성 제품과 접촉할 경우 사람에게도 발병할 수 있습니다.
또한 동물의 브루셀라증에는 RB51 백신, S19 백신, B19 백신 및 기타(45/20 백신, SR82 백신 등) 백신이 사용되고 있습니다.
또한 브루셀라증 백신 접종 프로그램의 도입 증가는 예측 기간 중 시장 성장을 촉진할 것으로 예상됩니다.
2021년 8월, 인도 마니푸르 주 투발에서 생후 4-8개월된 암소를 대상으로 브루셀라증 억제 및 근절을 위한 브루셀라 백신 접종 프로그램이 시작되었습니다.
시장 역학
브루셀라증 유병률의 증가는 예측 기간 중 글로벌 브루셀라증 백신 시장의 성장을 촉진할 것으로 예상됩니다. 예를 들어 생명공학 및 생의학 관련 일련의 데이터베이스를 운영하는 국립생물공학정보센터(NCBI)가 발표한 기사에 따르면 브루셀라증은 세계에서 가장 널리 퍼진 인수공통전염병으로 동물에서 인간으로 감염되는 질병의 일종이라고 합니다. 이 정보원에 따르면 전 세계에서 매년 50만 건의 인간 브루셀라증 사례가 보고되고 있습니다. 그러나 실제 발생 건수는 전 세계에서 연간 500만-1,250만 건으로 추정되고 있습니다.
이 정보원에 따르면 브루셀라증은 세계에서 가장 흔한 실험실 감염으로 인식되고 있습니다.
본 조사의 주요 특징
- 이 보고서는 2021년을 기준연도로 하여 예측 기간(2022-2030년)의 글로벌 브루셀라증 백신 시장, 시장 규모 및 CAGR%에 대한 상세한 분석을 제공합니다.
- 이 보고서는 각 부문의 잠재적 매출 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략에 대한 중요 인사이트도 제공합니다.
- 이 보고서는 다음과 같은 매개 변수를 기반으로 세계의 브루셀라증 백신 시장의 주요 기업 개요을 작성합니다. : 회사 개요, 제품 포트폴리오, 주요 하이라이트, 재무 성과 및 전략.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것입니다.
- 이 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계의 브루셀라증 백신 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있을 것입니다.
목차
제1장 조사의 목적과 전제조건
제2장 시장 범위
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 브루셀라증 백신 시장 : 유형별, 2026-2033년
제5장 세계의 브루셀라증 백신 시장 : 용도별, 2026-2033년
제6장 세계의 브루셀라증 백신 시장 : 지역별, 2026-2033년
제7장 경쟁 구도
제8장 섹션
KSA 26.05.04Brucellosis Vaccines Market is estimated to be valued at USD 1.2 Bn in 2026 and is expected to reach USD 2.4 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7.3% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 1.2 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 7.30% | 2033 Value Projection: | USD 2.4 Bn |
Brucellosis is an infectious disease caused by bacteria. Animals that are most commonly infected include sheep, cattle, goats, pigs, and dogs, among others. These disease can also occur in humans when they are in contact with infected animals or animal products contaminated with bacteria.
Moreover, RB51 Vaccine, S19 Vaccine, B19 Vaccine and Others (45/20 vaccine, SR82 vaccine, etc.) are the type of vaccine used for the brucellosis in animals.
Furthermore, increasing launches of brucellosis vaccination programmes is expected to drive the market growth over the forecast period.
In August 2021, brucella vaccination program was launched at Thoubal, Manipur, India for the control and eradication of brucellosis in female calves of 4-8 months age group.
Market Dynamics
Increasing prevalence of brucellosis is expected to drive the global brucellosis vaccines market growth over the forecast period. For instance, according to an article published by the National Center for Biotechnology Information, a series of databases relevant to biotechnology and biomedicine, brucellosis is the world's most widespread zoonotic disease, a type of disease that passes from an animal to a human. The source stated that there are a reported 500,000 cases of human brucellosis each year, globally. However, true incidence is estimated to be 5,000,000 to 12,500,000 cases each year, globally.
According to the same source, brucellosis is recognized as the world's most common laboratory-acquired infection.
Key features of the study
- This report provides an in-depth analysis of the global brucellosis vaccines market, market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global brucellosis vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Merck & Co., Inc., CZ Vaccines, Colorado Serum Company, Indian Immunologicals Ltd., Hester Biosciences Limited, Veterinary Technologies Corporation, Jordan Bio-industries Center, Laboratorios Tornel, Fivet Animal Health and VETAL Animal Health Products Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global brucellosis vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global brucellosis vaccines market
Market Segmentation
- By Type
- RB51 Vaccine
- S19 Vaccine
- B19 Vaccine
- Others (45/20 vaccine, SR82 vaccine, etc.)
- By Application
- Cattle
- Sheep
- Goat
- Others (swine, horses, etc.)
- By Regional Insights
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Merck & Co., Inc.
- CZ Vaccines
- Colorado Serum Company
- Indian Immunologicals Ltd.
- Hester Biosciences Limited
- Veterinary Technologies Corporation
- Jordan Bio-industries Center
- Laboratorios Tornel
- Fivet Animal Health
- VETAL Animal Health Products Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Type
- Market Snippet, By Application
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Drivers
- Restraints
- Opportunity
- Impact Analysis
- Market Trends
- Key Developments
- Product Launch
- Regulatory Guidelines
- Acquisitions, Collaborations, & Partnerships
- Epidemiology
- PEST Analysis
4. Global Brucellosis Vaccines Market, By Type, 2026 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021-2033
- Segment Trends
- RB51 Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- S19 Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- B19 Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others (45/20 vaccine, SR82 vaccine, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Brucellosis Vaccines Market, By Application, 2026 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021-2033
- Segment Trends
- Cattle
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Sheep
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Goat
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others (swine, horses, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Brucellosis Vaccines Market, By Region, 2026 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2021-2033
- North America
- Market Size and Forecast, By Type, 2021-2033, (USD Bn)
- Market Size and Forecast, By Application, 2021-2033, (USD Bn)
- Market Size and Forecast, By Country, 2021-2033, (USD Bn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Type, 2021-2033, (USD Bn)
- Market Size and Forecast, By Application, 2021-2033, (USD Bn)
- Market Size and Forecast, By Country, 2021-2033, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Type, 2021-2033, (USD Bn)
- Market Size and Forecast, By Application, 2021-2033, (USD Bn)
- Market Size and Forecast, By Country, 2021-2033, (USD Bn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Type, 2021-2033, (USD Bn)
- Market Size and Forecast, By Application, 2021-2033, (USD Bn)
- Market Size and Forecast, By Country, 2021-2033, (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Market Size and Forecast, By Type, 2021-2033, (USD Bn)
- Market Size and Forecast, By Application, 2021-2033, (USD Bn)
- Market Size and Forecast, By Country, 2021-2033, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Type, 2021-2033, (USD Bn)
- Market Size and Forecast, By Application, 2021-2033, (USD Bn)
- Market Size and Forecast, By Region/Country, 2021-2033, (USD Bn)
- South Africa
- Central Africa
- North Africa
7. Competitive Landscape
- Competitive Snapshot
- Merck & Co., Inc.
- Company Overview
- Application Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- CZ Vaccines
- Company Overview
- Application Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Colorado Serum Company
- Company Overview
- Application Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Indian Immunologicals Ltd.
- Company Overview
- Application Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Hester Biosciences Limited
- Company Overview
- Application Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Veterinary Technologies Corporation
- Company Overview
- Application Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Jordan Bio-industries Center
- Company Overview
- Application Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Laboratorios Tornel
- Company Overview
- Application Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Fivet Animal Health
- Company Overview
- Application Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- VETAL Animal Health Products Inc.
- Company Overview
- Application Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
8. Section
- References
- Research Methodology
- About us and Sales Contact
